A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)
Clinical trial NCT05039450 · COMPLETED
Trial details
- NCT number
- NCT05039450
- Sponsor
- Akero Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2023-12-15
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.